A potential role of insulin in increasing pituitary sensitivity to GnRH is supported by the observation that treatment with rosiglitazone, an insulin sensitizer, not only improves peripheral insulin sensitivity, but also reduces the LH concentrations in women with PCOS (128, 129). This evidence concerns the gene PLOD1 and polycystic ovary syndrome.